문준호 (경북대학교병원)님 | 한빛사연구자 > 한빛사

경북대학교병원

최종업데이트 2022.12.25.

Clinical impact of clonal hematopoiesis on severe COVID-19 patients without canonical risk factors
- Haematologica, Sep 15, 2022 | https://doi.org/10.3324/haematol.2022.280621
- 2022-09
- 생명과학
- 한빛사논문
Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT
- Blood Cancer J., Published: 01 December 2021, 11, Article number: 190 | https://doi.org/10.1038/s41408-021-00577-2
- 2021-12
- 의약학
- 한빛사논문
Combination treatment of copanlisib and gemcitabine in relapsed/refractory PTCL (COSMOS): An open-label phase 1/2 trial
- Ann. Oncol., Available online 25 December 2020 | https://doi.org/10.1016/j.annonc.2020.12.009
- 2020-12
- 의약학
- 한빛사논문
Next-generation sequencing based post-transplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse
- Blood, Prepublished online August 14, 2018 | doi: https://doi.org/10.1182/blood-2018-04-848028
- 2018-08
- 의약학
- 한빛사논문

연구자 ID

저자논문